CC1CN(S(=O)(=O)c2cccc(C(=O)OCC(=O)NCc3ccccc3)c2)CC(C)O1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?